Vaccine Development and Manufacturing Forum 2017（InnoVax Forum）

Event Date: Nov.15-16, 2017

Event Venue: Shanghai, PR. China

Event Website: www.innovaxsummit.com

 

2017 Key Discussions

• Overview and Trends for Vaccine Industry and Product Development

• China/Asian Vaccine R&D and Industry Outlook

• Quality Control and Manufacturing Excellence for Vaccine Products towards Global Market

• New Technologies for Vaccine Research and Antigen Discovery

• Modern Vaccine Design for the Improved Efficacy, Safety and Production

• Vaccine Adjuvant Technology and Therapeutic Vaccine Development

• Viral Challenge Studies and Animal Model

• Vaccine Clinical Development, Safety Evaluation and Immunogenicity Assessment

• Novel Vaccine Delivery System and Formulation

• Innovation in Vaccine Process Development and Manufacturing

• New/Alternative Manufacturing Platform for Vaccine Production

• Single-use Systems, Multiple Products Facility and Flexible Manufacturing

• Analytical Characterization, Control and Purification Development

• Quality by Design, High-throughput Vaccine Process Development

 

Keynote Speakers & Presentations

Margaret Liu, Principal, ProTherImmune; President of International Society for Vaccines

Session 1: The Future Landscape of Vaccine Product Development

Session 2: Emerging Infectious Disease and the role of Gene-based Vaccine

 

Ken Ishii, Director, Center for Vaccine and Adjuvant Research, NIBIOHN, Professor, Osaka University

Session Topic: Cutting-edge Science towards Next Generation Adjuvant and Immunotherapeutic Agent

 

Sha Ha, Director, Vaccine BioProcess R&D, Merck & Co. USA

Session Topic: Evaluation of antibody quality elicited by a replication defective HCMV vaccine

 

Partial Speakers Committee:

Prof. Honghai Wang, Director of Academia Committee of Shanghai Key Laboratory of TB, Fudan University

Charles Sia, Chief Technical Officer, Vaccine R&D, BravoVax Bio

Pele Chong, Senior VP, Vaccine R&D, United Biomedical Taiwan

Jung-Sun Yum, Executive Director, R&D Centre, Korea CHA Vaccine Institute

Fengcai Zhu, Vice Director, Professor, Jiangsu Center for Disease Prevention and Control

Yen-Hung Chow, Associate Principal Investigator, National Taiwan Health Research Institutes

Xia Jin, Distinguished Professor and Principal Investigator, Institute Pasteur of Shanghai, Chinese Academy of Sciences

Sean Du, Head of External R&D Asia Pacific, Global R&D, Sanofi Pasteur

David Shao, Chief Financial Officer, Yisheng Bio

Harry Pan, R&D Director, Xiamen InnoVax Biotech

Prof. Yue-chun Kim, Assistant Professor, Korea Advanced Institute of Science and Technology

Prof. Ze Chen, Professor, Shanghai Institute of Biological Products

Tao Peng, Chief Scientific Officer, Guangdong South China United Vaccine institute

 

This forum also provides certain complimentary passes to professionals from vaccine manufacturers (with no products currently licensed/marketed) and research institutes. Seats are limited. Please contact the committee for the latest availability and suitability.

 

For more information on agenda, speaking, exhibiting and supporting opportunities, please contact:

 

Wei Zhang

Program Manager

Organizing Committee

InnoVax Forum: Vaccine Development and Manufacturing Forum 2017

Tel: 86.21.6034.0229

Email: wzhang@deliver-consulting.com

Website: www.innovaxsummit.com